Recent advances in the fight against non-small cell lung cancer (NSCLC) have brought new hope for patients carrying KRAS mutations, thanks to a breakthrough discovery by researchers at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. This advancement revolves around the repurposing of
In a groundbreaking study conducted by researchers at UF Health Cancer Center and their international partners, scientists have found compelling evidence that a toxin produced by a common foodborne bacterium, Campylobacter jejuni (C. jejuni), significantly accelerates the spread of colorectal
Prostate cancer has become an alarming health issue, particularly among African men, who are increasingly found to be at higher risk compared to men of other ethnicities. Various studies point towards genetic factors playing a significant role in this elevated risk, coupled with inadequate
Recent research from Weill Cornell Medicine has unveiled a promising preclinical discovery that could significantly enhance the effectiveness of cancer immunotherapy for B-cell non-Hodgkin lymphomas (B-NHL). The study focuses on the use of EZ## inhibitors, an emerging class of anticancer drugs, in
The field of organic chemistry has witnessed a significant breakthrough with the development of a highly (E)-selective Weinreb amide-type Horner–Wadsworth–Emmons (HWE) reaction. This advancement was achieved by a team from the Department of Applied Chemistry at Tokyo University of Science (TUS) in
In a remarkable breakthrough in breast cancer treatment, a novel cell-based immunotherapy developed by Dr. Gary Koski from Kent State University and Dr. Brian J. Czerniecki from the Moffitt Cancer Center has been recently accepted for publication in JAMA Oncology. This innovative approach harnesses
